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Background: Contaminated nebulizers are a potential source of bacterial infection but no single method is universally accepted for disinfection. We
hypothesized that baby-bottle steam sterilizers effectively disinfect home nebulizers.
Methods: Home nebulizers were inoculated with the common CF respiratory pathogens methicillin resistant Staphylococcus aureus, Burkholderia
cepacia, Haemophilus influenzae, mucoid and non mucoid Pseudomonas aeruginosa, and Stenotrophomonas maltophilia. The nebulizers were
swabbed for bacterial growth, treated with either the AVENT (Philips), the NUK Quick & Ready (Gerber) or DRY-POD (Camera Baby) baby
bottle steam sterilizer and reswabbed for bacterial growth.
Results: All steam sterilizers were effective at disinfecting all home nebulizers. Viable bacteria were not recovered from any inoculated site after
steam treatment, under any conditions tested.
Conclusions: Steam treatment is an effective disinfection method. Additional studies are needed to conﬁrm whether these results are applicable
to the clinical setting.
© 2012 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.Keywords: Disinfection; Nebulizers; Steam sterilization; Bacterial pathogens1. Introduction
Home nebulizer therapy is an integral part of treatment
regimens for patients with Cystic Fibrosis (CF). Benefits
include the delivery of therapies such as antibiotics to the site
of infection while reducing the systemic side effects. The risk
of bacterial colonization of home nebulizers varies depending
on the study but several studies report that home nebulizers
used by asthmatics or CF patients may become colonized with
bacteria [1–5]. This is not surprising as bacterial pathogens
such as Pseudomonas aeruginosa survive in water and can⁎ Corresponding author at: Department of Medical Sciences, Frank H. Netter
D, School of Medicine at Quinnipiac University, Hamden, CT 06518, United
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http://dx.doi.org/10.1016/j.jcf.2012.11.013colonize both plastic surfaces and human lungs via the for-
mation of bacterial biofilms [6].
The recognition that bacterial colonization of home nebulizers
is a potential risk for respiratory infection has led experts to
examine many different methodologies for disinfection. These
include cleaning with 2.0–3.5% acetic acid, soaking with water,
washing with soap and water (either tap or sterile), 70–90%
ethanol or isopropyl alcohol, 3% hydrogen peroxide, or 0.5%
hypochlorite [7–11]. Ideally, the method used to clean and
disinfect nebulizers, needs to be simple and efficient as to not
add to the growing treatment burden that could significantly
compromise patient adherence to therapy. Tai et al. reported
that soaking a nebulizer for 10 min in water followed by a rinse
was more effective at removing contaminated Escherichia coli
than either soaking or rinsing alone [12]. Sterile water was not
superior to tap water in this study and bacteria were recoveredby Elsevier B.V. All rights reserved.
513D Towle et al. / Journal of Cystic Fibrosis 12 (2013) 512–516from most sites even after soaking and rinsing. Rosenfeld et
al. found that aggressive tap water rinse sterilized 17/19
nebulizers inoculated with Staphylococcus aureus and mucoid
and non-mucoid P.aeruginosa [7]. Reychler compared five
methods of disinfection, hypochlorite solution, 3.5% acetic
acid, 0.5% Hexanios, 0.5% washing detergent, and a dishwasher,
using facemasks and mouthpieces inoculated with common
CF pathogens (S. aureus, P. aeruginosa, Stenotrophomonas
maltophilia, Burkholderia cenocepacia, and Alcaligenes
xylosoxydans). The authors found that all were effective except
acetic acid for the treatment of S. aureus [9]. In a separate study
Reychler et al. found that environmental organisms but not the
CF pathogens, methicillin sensitive S. aureus or S.maltophilia,
were cleared from CF patient nebulizers with 0.5% hypochlo-
rite [8]. Given that rinsing or soaking in tap water is efficacious
in disinfecting home equipment in previous studies, it is likely
that home steam-sterilizers, commonly used and sold for baby
bottles, will also be effective. Brief exposure to steam (3 s)
can effectively decontaminate a variety of surfaces and eradicate
N99.5% of an existing bacterial biofilm [13]. Steam-sterilization
is recommended to disinfect the Altera® nebulizer that delivers
inhaled aztreonam (http://www.cff.org/treatments/Therapies/
Respiratory/Cayston/). Importantly, repeated steam steriliza-
tion treatments do not impair the in vitro function of the eFlow®
rapid nebulizer [14]. The procedure is fast, straightforward,
and easy to perform making it an ideal method for disinfection.
However, there is little published data on whether steam
sterilization effectively disinfects home nebulizers. Therefore
we sought to examine the effectiveness of three different
commercially available baby-bottle steam sterilizers for their
ability to disinfect nebulizers inoculated in vitro with res-
piratory pathogens commonly isolated from CF patients.
2. Methods
2.1. Bacterial strains and growth conditions
Table 1 lists the strains inoculated onto the nebulizers to
test for disinfection. Bacteria were grown overnight on blood
agar plates (Remel, Lenexa, KS), inoculated into Trypticase
Soy Broth (TSB) (Remel, Lenexa, KS) at a density of 0.5Table 1
Bacterial strains tested for steam-treatment.
Bacteria Source Estimated inoculum a
Pseudomonas aeruginosa ATCC 27853 9.2×105
Mucoid Pseudomonas aeruginosa Clinical isolate 5.7×105
Methicillin resistant ATCC 4330 6.5×105
Staphylococcus aureus
Methicillin susceptible ATCC 25923 1×107
Staphylococcus aureus
Haemophilus influenzae ATCC 10211 1.3×106
Burkholderia cepacia ATCC 25416 3.8×105
Stenotrophomonas maltophilia ATCC 51331 6.0×105
a Inoculum based on serial dilutions of 5.0–0.5 McFarland suspensions.McFarland. Ten microliters of this suspension was used to
inoculate the nebulizers. To determine the pre-exposure inocu-
lum, the 0.5 McFarland suspension of each bacterial strain
was serially diluted, the diluted bacterial suspensions inocu-
lated on blood agar plates for 48 h at 37 °C, and the colony
forming units recorded (Table 1).2.2. Nebulizer inoculation
For all conditions three different nebulizers, the Pari LC
Plus®. eFlow® rapid, and eFlow Altera®, were inoculated with
each of the above bacterial strains in three different locations
for each individual experiment (Fig. 1). Initially, the disinfec-
tion of both unassembled and fully assembled nebulizers was
compared. Assembled nebulizers were inoculated prior to as-
sembly and then put together prior to steam treatment. Once we
determined that there was no difference in bacterial recovery
comparing assembled with the unassembled nebulizers (data
not shown), all remaining experiments were performed on
fully assembled nebulizers.
Three different conditions were tested: 1) Dry samples: The
nebulizer inoculated with the 10 μl bacterial suspensions was
air dried in a hood for 30 min and then was subjected to steam
sterilization treatment. 2) Wet samples: The nebulizer with the
10 μl bacterial suspensions was immediately placed in the
sterilizer. 3) Sputum samples: A pool of de-identified discarded
sputum that had grown only normal flora recovered from three
unknown CF patients was vortexed and 0.5 ml was transferred to
a microfuge tube. Since the specimens were pooled de-identified
sputum being discarded by the clinical microbiology laboratory,
this study meets the criteria as being exempt from review by the
Yale Human Investigations Committee. Ten microliters of 0.5
McFarland bacterial suspension was transferred to the sputum
containing microfuge tube and 10 μl of each seeded sputum was
inoculated to the three different sites on each nebulizer. An
un-inoculated sputum sample was used as a control in these
experiments. The sputum contained normal flora (Fig. 2) so the
amount of bacteria recovered from the inoculated sputum was
determined using the 4 quadrant semi-quantitative streaking
method commonly used in clinical microbiology laboratories.
With this method 1+ represents bacterial growth in the first
quadrant only, 2+ in the first and second quadrant, 3+ the first
three quandrants, and 4+ all streaked quadrants.
In a separate set of experiments we usedmucoid P. aeruginosa
and S. aureus with a 5.0 McFarland suspension, performed
serial dilutions to quantitate the bacterial amount, and either
inoculated the nebulizer directly or seeded 100 μl of sputum
with 10 μl each of the higher bacterial inoculum and per-
formed the experiments as described above. Additional ex-
periments with 5.0 MacFarland mucoid P. aeruginosa and
S. aureus included both 24 and 48 h bacterial incubation times
to allow for potential biofilm formation prior to steam treat-
ment. For 24 and 48 h incubation experiments, the water
rinsing method of Rosenfeld et al. was performed as described
to determine how steam treatment compared with a published
disinfection protocol [7].
Fig. 1. Bacterial inoculation sites. The nebulizers Pari LC Plus® (A) and eFlow®rapid (B) were disassembled for inoculation and then reassembled prior to steam
treatment for experiments after the initial comparison of assembled and disassembled steam treatments. The Altera® was inoculated as shown for the eFlow® rapid.
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Three different steam sterilizers, NUK Quick 'n Ready
Steam Sterilizer (Gerber) the AVENT 3-in-1 Electric Steam
Sterilizer (Philips) and the DRY-POD Sterilizer (Camera Baby)
were used per the manufacturer's instructions for all experi-
ments. Nebulizers were steam treated for approximately 10 min
in each machine using tap water. The nebulizers were allowed
to cool for 10 min prior to removal from the steam sterilizer.
The previously inoculated sites were wiped with a sterile cotton
swab dipped in 0.45% saline that was then used to streak a blood
agar plate, the plate incubated at 37 °C and examined for growth
at 48 h. Each steam sterilizer was used for each nebulizer under
each of the three conditions (dry, wet and sputum) tested for each
bacterial strain.
As a mock control, an inoculated nebulizer was placed in
each sterilizer (turned off) for 10 min and then removed. A sterile
swab was dipped in sterile 0.45% saline and each area previously
inoculated with bacteria was vigorously swabbed individually
and plated on separate blood agar plates as described above for
the treated nebulizers.Fig. 2. Pretreatment growth of bacteria from de-identified pooled CF sputum
inoculated with P. aeruginosa. The chocolate agar (A) and blood agar plates
(C) show both the laboratory inoculatedP. aeruginosa and the mixed normal flora.
The colistin nalidixic acid agar plate (B) that selects for gram positive organisms
shows only mixed normal flora (e.g. white colonies) and no P. aeruginosa while
the MacConkey agar plate (D) that is selective for gram negative bacterium shows
only P. aeruginosa. No bacteria were recovered after steam treatment from any
plates.3. Results
We were initially interested in whether steam-sterilization
would work equally well comparing an unassembled nebulizer
with a fully assembled nebulizer. To test this we used non-mucoid
P. aeruginosa as the test organism with each nebulizer. After
nebulizer bacterial inoculation under dry conditions and steam
treatment with either the NUK or AVENT machines, we did not
recover viable bacteria from either the unassembled or fully
assembled nebulizer (data not shown). Thus all remaining ex-
periments were performed on assembled nebulizers.
The bacterial inoculums for the initial nebulizer experiments
as determined by serial dilutions of the bacterial suspensions
are listed in Table 1. After steam sterilization treatment with each
of the three machines we did not recover any viable bacterium
from any of the nebulizers tested, regardless of the bacterium
used or whether the sample was wet or left to dry (Table 2). We
hypothesized that the presence of sputum might provide some
protection from the effects of steam treatment so we inoculated
de-identified pooled CF sputum with the bacterial pathogens.
We still did not recover viable bacteria after steam treatment,
regardless of the strain, machine, or nebulizer (Table 3, Fig. 2).
The normal flora in the pooled CF sputum samples also was
not recovered post-treatment suggesting upper respiratory floraTable 2




Treatment Conditions Mock Steam Mock Steam Mock Steam
H. influenza Wet/dry 4+ N.G. 4+ N.G. 4+ N.G.
B. cepacia Wet/dry 4+ N.G. 4+ N.G. 4+ N.G.
S. maltophilia Wet/dry 4+ N.G. 4+ N.G. 4+ N.G.
S. aureus (MRSA) Wet/dry 4+ N.G. 4+ N.G. 4+ N.G.
S. aureus
(MSSA)#
24 h 3+ N.G. 3+ N.G. 3+ N.G.
Mucoid Wet/dry 4+ N.G. 4+ N.G. 4+ N.G.
P. aeruginosa# 24 h 1+ N.G. 1+ N.G. 1+ N.G.
P. aeruginosa Wet/dry 4+ N.G. 4+ N.G. 4+ N.G.
*Results were identical for all three baby-bottle steam sterilizers tested, all
inoculation sites, and for both wet (immediate treatment) and dry (30 minute
drying in hood) conditions. Estimated inoculums are in Table 1. # These
bacterial suspensions were left on the nebulizers 24 h at room temperature
before swabbing and treatment. 1+ represents 2–95 colonies depending on the
inoculum site. 4+ represents N100,000 bacterial colony forming units. N.G.=
No growth.
Table 3
Sputum does not protect bacteria from steam sterilization*.
Pari LC Plus® eFlow® rapid Altera®
Treatment Time Mock Steam Mock Steam Mock Steam
H. influenzae 30 min 3+ N.G. 3+ N.G. 3+ N.G.
B. cepacia 30 min 3+ N.G. 3+ N.G. 3+ N.G.
S. maltophilia 30 min 3+ N.G. 3+ N.G. 3+ N.G.
S. aureus (MRSA) 30 min 3+ N.G. 3+ N.G. 3+ N.G.
S. aureus (MSSA) 24 h 3+ N.G. 3+ N.G. 3+ N.G.
48 h 3+ N.G. 3+ N.G. 3+ N.G.
Mucoid 30 min 3+ N.G. 3+ N.G. 3+ N.G.
P. aeruginosa 24 h 1–2+ N.G. 2+ N.G. 2+ N.G.
48 h 1–2+ N.G. 1–2+ N.G. 1–2+ N.G.
P. aeruginosa 30 min 3+ N.G. 3+ N.G. 3+ N.G.
*Results were identical for all three steam sterilizers tested and all inoculation
sites. Mixed normal flora was present in each sample that was not recovered
after steam sterilization. N.G.=No growth.
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increase the inoculum for mucoid P. aeruginosa and S. aureus,
both in the presence and absence of sputum to reach a number
where viable bacteria might be recovered after steam-treatment.
Three ×107 S. aureus or 2.6×107 mucoid P. aeruginosa were
inoculated onto the nebulizer and 1.5×106 S. aureus or 1.3×106
mucoid P. aeruginosa mixed in de-identified pooled CF sputum
were inoculated onto the nebulizers, left for 30 min, and
subjected to steam treatment. Again no viable bacteria were
recovered after steam exposure compared with the mock treat-
ment where bacterial growth was present (data not shown).
Since mucoid P.aeruginosa has a propensity to form
biofilms on plastic, we next examined the effectiveness of
steam treatment when bacteria were left on the nebulizers for
either 24 or 48 h prior to treatment both in the presence and
absence of CF sputum. Interestingly, mucoid P. aeruginosa
from a liquid suspension had decreased viability after 24 h on
the nebulizers prior to steam treatment (Table 2). This is in
contrast to S. aureus where 3+ organisms were recovered from
every nebulizer at each inoculation site (Table 2). When mucoid
P. aeruginosa was added to de-identified pooled CF sputum,
and inoculated on the nebulizers, both the P. aeuginosa and
normal flora remained viable after 24 and 48 h, confirming that
the sputum enhanced bacterial viability (Table 3). After steam
treatment no organisms were recovered from any inoculation
site from any nebulizer with or without sputum, confirming
that steam treatment works even after organisms survive on the
plastic for up to 48 h (Tables 2, 3).
Rosenfeld et al. have shown that vigorous rinsing in water
alone may be sufficient to disinfect nebulizers and this protocol
was used as a control in experiments with 24 h bacterial
incubation times [7]. With this protocol no mucoid P. aeruginosa
was recovered from any nebulizer from any inoculum site +/−
sputum. S. aureus inoculated without sputum was recovered only
from the PARI LC Plus nebulizer with 14 colonies, 1 colony,
and 1 colony found at respective inoculum sites. The other
nebulizers had no S. aureus growth after water rinsing at all
sites (data not shown). In contrast, when S. aureus was added
to sputum on the nebulizer for 24 h prior to rinsing, bacteriawere recovered at 8/9 inoculation sites with growth ranging
from 1+ to 3+ (data not shown).4. Discussion
Many different methods have been proposed, tested, and
recommended for the disinfection of home nebulizers [7–9,11].
The ideal method should be effective and user-friendly, without
altering the ability of the machine to deliver the necessary
medications. It is clear that nebulized therapies add a level
of complexity and time to CF treatment plans resulting in a
significant treatment burden. Moreover, increased treatment
burdens are often associated with a decrease in adherence to
treatment regimens [15]. More importantly, in CF decreased
adherence has been shown to correlate with poorer lung health,
therefore a fast reliable method of cleaning is extremely im-
portant to this patient cohort [15]. A Belgian study found that
only 57% of patients cleaned home inhalation devices daily as
recommended [16]. A rapid and easy disinfection method would
potentially improve adherence to daily disinfection and be
consistent with other proposed strategies to reduce the treat-
ment burden [17].
Currently steam sterilization is one of many options rec-
ommended for the disinfection of home respiratory equipment
and this in vitro data suggests that it is an effective method
to disinfect home nebulizers with respect to common CF
pathogens. Importantly we only compared steam sterilization
to washing with water and not other techniques published in
the literature so we cannot confirm if these other methods
would have been as effective as steam sterilization under the
conditions tested. However, compared with previously pub-
lished similar studies, steam sterilization performs as well or
better than other disinfection methods [7,9]. We found no
difference in mucoid P. aeruginosa recovery comparing steam
treatment and rinsing with water with both being equally
effective. We hypothesize this is because the rinsing method
allows for an overnight drying step before swabbing for growth
and our data suggest that the mucoid P. aeruginosa in this
study is sensitive to dessication. Alternatively, more S. aureus
survived 24 h on the nebulizer and while water rinsing was
generally effective in the absence of sputum, when mixed with
sputum S. aureus was recovered from virtually all sites after
rinsing compared with steam treatment where no organisms
were recovered.
Increasing the inoculum to 107 P. aeruginosa or S. aureus
did not result in the recovery of viable bacteria after steam
treatment, regardless of the brand of baby bottle steam sterilizer
used, the location of the bacterial inoculum, or the type of
nebulizer. While we did not recover viable bacteria after steam
“sterilization”, our experiments are not rigorous enough to
determine if the nebulizers were truly sterile, only that there
was at least 5× log killing in all experiments. We cannot exclude
small amounts of viable persister bacteria that were not picked
up by swabs and were below the limit of detection. Ultrasound
may enhance the ability to recover these organisms but is not
routine practice in most clinical microbiology laboratories.
516 D Towle et al. / Journal of Cystic Fibrosis 12 (2013) 512–516This study supports recommendations to use steam sterili-
zation as a method for disinfection. While fully assembled
nebulizers are disinfected in vitro with this method, it does not
replace the need to break down the nebulizer for routine
cleaning to remove any drug residue. The studied nebulizers
were subject to multiple exposures with the same inoculum
sites being steam treated multiple times by each machine (n=35
exposures/machine). The number of steam treatments a single
machine can perform before it is no longer effective remains
unknown. This is important because there are currently no
controls available for patients to ensure that the machine worked
properly during each run. Additionally, these are in vitro ex-
periments and while we hypothesize that steam sterilization
will be effective when applied to actual patient nebulizers,
this requires additional clinical studies. These experiments are
set up in the laboratory under tightly controlled conditions
with characterized strains and do not reflect the microbial
variability present in the CF population. It is possible that
steam sterilization may be less effective against individual
patient strains of bacterial pathogens with mutations that
confer resistance to steam treatment or other pathogens not
tested here (e.g. atypical mycobacterium). These are active
areas of investigation.
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